US Centers for Disease Control recommends an annual oral cancer screening for everyone over 17 years of age. Oral cancers are usually not found until the late stages but early detection is the key to making them very treatable.
Using fluorescence can detect abnormalities not visible under normal light.
OralID uses a proven, optically based technology called, "fluorescence technology." OralID's fluorescence technology uses a blue light (435–460 nm) that allows a clinician to identify oral cancer, pre-cancer and other abnormal lesions at an earlier stage, thus saving lives. The medical applications of fluorescence technology includes diagnosis of the GI tract, cervix, lung, skin and oral mucosa.